Concepedia

Xiang Li

XL

Statistics

Publications

34

Citations

1.1K

H-Index

21

Active since

2010

Affiliations

Zhengzhou University(Current)

Henan Cancer Hospital

China-US (Henan) Hormel Cancer Institute

University of Minnesota

Hormel (United States)

Xiang Li is an author at Zhengzhou University specializing in oncology, medicine, and cancer cell signaling.

ORCID

Publications per year

2010–2025

34

Publications

34

Chrysin suppresses proliferation, migration, and invasion in glioblastoma cell lines via mediating the ERK/Nrf2 signaling pathway

Juan Wang, Kangjian Sun, Xiaoliang Wang et al. · Drug Design Development and Therapy · 2018 · 94 citations · Full text

, , +16

Phosphorylation of Caspase-7 by p21-activated Protein Kinase (PAK) 2 Inhibits Chemotherapeutic Drug-induced Apoptosis of Breast Cancer Cell Lines

Xiang Li, Weihong Wen, Kangdong Liu et al. · Journal of Biological Chemistry · 2011 · 79 citations · Full text

, , +17

Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma

Lei Qin, Xiang Li, Amanda Stroiney et al. · Neuroradiology · 2017 · 65 citations · Full text

, , +17

CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction

Yiu To Yeung, Suyu Fan, Bingbing Lu et al. · Carcinogenesis · 2019 · 65 citations · Full text

, , +17

CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway

Chuntian Huang, Ruijuan Du, Xuechao Jia et al. · Cell Death and Differentiation · 2021 · 57 citations · Full text

, , +14

1–5 of 34